000258919 001__ 258919
000258919 005__ 20231120155349.0
000258919 0247_ $$2doi$$a10.1016/S1474-4422(23)00131-X
000258919 0247_ $$2pmid$$apmid:37236211
000258919 0247_ $$2ISSN$$a1474-4422
000258919 0247_ $$2ISSN$$a1474-4465
000258919 0247_ $$2altmetric$$aaltmetric:148884872
000258919 037__ $$aDZNE-2023-00691
000258919 041__ $$aEnglish
000258919 082__ $$a610
000258919 1001_ $$aDuering, Marco$$b0
000258919 245__ $$aNeuroimaging standards for research into small vessel disease-advances since 2013.
000258919 260__ $$aLondon$$bLancet Publ. Group$$c2023
000258919 3367_ $$2DRIVER$$aarticle
000258919 3367_ $$2DataCite$$aOutput Types/Journal article
000258919 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1692960377_28578$$xReview Article
000258919 3367_ $$2BibTeX$$aARTICLE
000258919 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000258919 3367_ $$00$$2EndNote$$aJournal Article
000258919 520__ $$aCerebral small vessel disease (SVD) is common during ageing and can present as stroke, cognitive decline, neurobehavioural symptoms, or functional impairment. SVD frequently coexists with neurodegenerative disease, and can exacerbate cognitive and other symptoms and affect activities of daily living. Standards for Reporting Vascular Changes on Neuroimaging 1 (STRIVE-1) categorised and standardised the diverse features of SVD that are visible on structural MRI. Since then, new information on these established SVD markers and novel MRI sequences and imaging features have emerged. As the effect of combined SVD imaging features becomes clearer, a key role for quantitative imaging biomarkers to determine sub-visible tissue damage, subtle abnormalities visible at high-field strength MRI, and lesion-symptom patterns, is also apparent. Together with rapidly emerging machine learning methods, these metrics can more comprehensively capture the effect of SVD on the brain than the structural MRI features alone and serve as intermediary outcomes in clinical trials and future routine practice. Using a similar approach to that adopted in STRIVE-1, we updated the guidance on neuroimaging of vascular changes in studies of ageing and neurodegeneration to create STRIVE-2.
000258919 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000258919 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000258919 650_2 $$2MeSH$$aHumans
000258919 650_2 $$2MeSH$$aNeurodegenerative Diseases
000258919 650_2 $$2MeSH$$aActivities of Daily Living
000258919 650_2 $$2MeSH$$aNeuroimaging
000258919 650_2 $$2MeSH$$aMagnetic Resonance Imaging: methods
000258919 650_2 $$2MeSH$$aBrain: diagnostic imaging
000258919 650_2 $$2MeSH$$aCognitive Dysfunction
000258919 650_2 $$2MeSH$$aCerebral Small Vessel Diseases: diagnostic imaging
000258919 7001_ $$aBiessels, Geert Jan$$b1
000258919 7001_ $$aBrodtmann, Amy$$b2
000258919 7001_ $$aChen, Christopher$$b3
000258919 7001_ $$aCordonnier, Charlotte$$b4
000258919 7001_ $$ade Leeuw, Frank-Erik$$b5
000258919 7001_ $$aDebette, Stéphanie$$b6
000258919 7001_ $$aFrayne, Richard$$b7
000258919 7001_ $$aJouvent, Eric$$b8
000258919 7001_ $$aRost, Natalia S$$b9
000258919 7001_ $$aTer Telgte, Annemieke$$b10
000258919 7001_ $$aAl-Shahi Salman, Rustam$$b11
000258919 7001_ $$aBackes, Walter H$$b12
000258919 7001_ $$aBae, Hee-Joon$$b13
000258919 7001_ $$aBrown, Rosalind$$b14
000258919 7001_ $$aChabriat, Hugues$$b15
000258919 7001_ $$aDe Luca, Alberto$$b16
000258919 7001_ $$adeCarli, Charles$$b17
000258919 7001_ $$aDewenter, Anna$$b18
000258919 7001_ $$aDoubal, Fergus N$$b19
000258919 7001_ $$0P:(DE-HGF)0$$aEwers, Michael$$b20
000258919 7001_ $$aField, Thalia S$$b21
000258919 7001_ $$aGanesh, Aravind$$b22
000258919 7001_ $$aGreenberg, Steven$$b23
000258919 7001_ $$aHelmer, Karl G$$b24
000258919 7001_ $$aHilal, Saima$$b25
000258919 7001_ $$aJochems, Angela C C$$b26
000258919 7001_ $$aJokinen, Hanna$$b27
000258919 7001_ $$aKuijf, Hugo$$b28
000258919 7001_ $$aLam, Bonnie Y K$$b29
000258919 7001_ $$aLebenberg, Jessica$$b30
000258919 7001_ $$aMacIntosh, Bradley J$$b31
000258919 7001_ $$aMaillard, Pauline$$b32
000258919 7001_ $$aMok, Vincent C T$$b33
000258919 7001_ $$aPantoni, Leonardo$$b34
000258919 7001_ $$aRudilosso, Salvatore$$b35
000258919 7001_ $$aSatizabal, Claudia L$$b36
000258919 7001_ $$aSchirmer, Markus D$$b37
000258919 7001_ $$aSchmidt, Reinhold$$b38
000258919 7001_ $$aSmith, Colin$$b39
000258919 7001_ $$aStaals, Julie$$b40
000258919 7001_ $$aThrippleton, Michael J$$b41
000258919 7001_ $$avan Veluw, Susanne J$$b42
000258919 7001_ $$aVemuri, Prashanthi$$b43
000258919 7001_ $$aWang, Yilong$$b44
000258919 7001_ $$aWerring, David$$b45
000258919 7001_ $$aZedde, Marialuisa$$b46
000258919 7001_ $$aAkinyemi, Rufus O$$b47
000258919 7001_ $$aDel Brutto, Oscar H$$b48
000258919 7001_ $$aMarkus, Hugh S$$b49
000258919 7001_ $$0P:(DE-HGF)0$$aZhu, Yi-Cheng$$b50
000258919 7001_ $$aSmith, Eric E$$b51
000258919 7001_ $$0P:(DE-2719)2000030$$aDichgans, Martin$$b52$$udzne
000258919 7001_ $$aWardlaw, Joanna M$$b53
000258919 773__ $$0PERI:(DE-600)2079704-7$$a10.1016/S1474-4422(23)00131-X$$gVol. 22, no. 7, p. 602 - 618$$n7$$p602 - 618$$tThe lancet <London> / Neurology$$v22$$x1474-4422$$y2023
000258919 8564_ $$uhttps://www.sciencedirect.com/science/article/pii/S147444222300131X
000258919 8564_ $$uhttps://pub.dzne.de/record/258919/files/DZNE-2023-00691_Restricted.pdf
000258919 8564_ $$uhttps://pub.dzne.de/record/258919/files/DZNE-2023-00691_Restricted.pdf?subformat=pdfa$$xpdfa
000258919 909CO $$ooai:pub.dzne.de:258919$$pVDB
000258919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000030$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b52$$kDZNE
000258919 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000258919 9141_ $$y2023
000258919 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-09
000258919 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-09
000258919 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-24
000258919 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-24
000258919 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-24
000258919 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-24
000258919 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLANCET NEUROL : 2022$$d2023-10-24
000258919 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-24
000258919 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-24
000258919 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-24
000258919 915__ $$0StatID:(DE-HGF)9940$$2StatID$$aIF >= 40$$bLANCET NEUROL : 2022$$d2023-10-24
000258919 9201_ $$0I:(DE-2719)5000022$$kAG Dichgans$$lVascular Cognitive Impairment & Post-Stroke Dementia$$x0
000258919 980__ $$ajournal
000258919 980__ $$aVDB
000258919 980__ $$aI:(DE-2719)5000022
000258919 980__ $$aUNRESTRICTED